-

Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes

The first initiative will support Look Good Feel Better® during Breast Cancer Awareness Month

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the launch of Wings by Evolus, a new charitable platform designed to bring together aesthetic practices, providers, and patients to support organizations and causes that positively impact their communities.

The first Wings by Evolus initiative will launch in October in recognition of Breast Cancer Awareness Month in support of Look Good Feel Better®, a global cancer support program dedicated to helping people manage the appearance-related effects of cancer treatment and restore confidence through free beauty-focused workshops and resources. The initiative reflects a shared belief in the importance of confidence and provides an opportunity for the Evolus community to support people affected by cancer.

Throughout October, Evolus will donate $1 to the Look Good Feel Better Foundation for every Evolus Rewards® patient check-in at a participating practice. Practices can participate by opting into the initiative through the Evolus customer portal, with no cost to the practice or patient and no change to the existing Evolus Rewards® check-in experience.

“At Evolus, we’ve built a community that includes thousands of aesthetic injectors and millions of patients, giving us a unique opportunity to make a meaningful impact when we come together,” said David Moatazedi, President and Chief Executive Officer of Evolus. “Wings by Evolus creates a platform to harness the collective strength of that community in support of important causes. We are proud to begin with Look Good Feel Better®, an organization whose mission has a natural connection to our industry and the important role confidence can play in people’s lives.”

Wings by Evolus was created to extend the connection between Evolus, its customers, and consumers beyond the treatment setting by providing opportunities to collectively support charitable organizations and important causes. Inspired by the butterfly as a symbol of transformation, the platform reflects Evolus’ belief that the scale of its community can be leveraged to create meaningful positive impact.

Look Good Feel Better® provides free programs and resources to help people manage the appearance-related effects of cancer treatment. Its programs include beauty-focused workshops that teach techniques to help people manage appearance-related changes during cancer treatment, virtual educational resources, and support delivered through a global network of licensed affiliates.

“We are grateful to Evolus for selecting Look Good Feel Better® as the first organization supported through Wings by Evolus,” said Christopher Barrett Politan, Interim Executive Director of the Look Good Feel Better Foundation. “Support from Evolus and its community will help us continue providing free programs and resources that help people facing cancer manage appearance-related changes and feel supported throughout treatment.”

The first Wings by Evolus initiative will run from October 1 through October 31, 2026. Participating practices can learn more and opt into the initiative through the Evolus customer portal. Additional information about Look Good Feel Better® and its program is available at lookgoodfeelbetter.org.

About Evolus, Inc.

Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics by building a differentiated portfolio of injectable brands that address the evolving needs of practitioners and patients. Our portfolio includes Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, Evolysse®, a collection of unique injectable hyaluronic acid (HA) gels, and Profhilo®, the market-leading injectable for skin quality in Europe, which Evolus has exclusively licensed for development and commercialization in the United States. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.

About Look Good Feel Better®

Look Good Feel Better® is the global beauty industry’s charitable initiative to support the confidence and wellbeing of people facing cancer. Since 1989, the program has reached millions in over 27 countries, helping individuals manage the visible side effects of treatment through expert-led beauty and wellness education. Through partnerships with leaders across the global beauty industry, Look Good Feel Better® offers free workshops that empower people with cancer to face treatment with resilience, dignity, and strength. Learn more about our global impact and upcoming programs at www.lookgoodfeelbetter.org.

Jeuveau® and Nuceiva®, and Evolysse® are registered trademarks of Evolus, Inc.
Estyme® is a trademark of Symatese Aesthetics S.A.S.
Jeuveau® (known as Nuceiva® outside the United States) and Evolysse® (known as Estyme® outside the United States) are referred to throughout this press release by their U.S. trade names for convenience.
Profhilo® is a registered trademark of IBSA Institut Biochimique SA
Look Good Feel Better® is a registered trademark of the Look Good Feel Better Foundation.

Contacts

Evolus Contacts:
Investors:
Nareg Sagherian
Vice President, Head of Global Investor Relations and Corporate Communications
Tel: 248-202-9267
Email: ir@evolus.com

Media:
Email: media@evolus.com

Evolus

NASDAQ:EOLS
Details
Headquarters: Newport Beach, CA
CEO: David Moatazedi
Employees: 150
Organization: PUB

Release Versions

Contacts

Evolus Contacts:
Investors:
Nareg Sagherian
Vice President, Head of Global Investor Relations and Corporate Communications
Tel: 248-202-9267
Email: ir@evolus.com

Media:
Email: media@evolus.com

More News From Evolus

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the second quarter ended June 30, 2026. “The increasing momentum of our portfolio focus has resulted in Evolus gaining significant share across injectable aesthetics during the second quarter, supported by double-digit growth for Jeuveau® and accelerating adoption of Evolysse®,” said...

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has expanded its partnership with Symatese through an amendment to the companies’ existing licensing and distribution agreement, providing Evolus with the exclusive rights to commercialize the Estyme® (pronounced “esteem”) collection of injectable hyaluronic acid (HA) gels in Canada, Australia, and New Zea...

Evolus to Report Second Quarter Financial Results on August 5, 2026

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the U.S. financial markets close.Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow management’s remarks.To pa...
Back to Newsroom